MEDIFAST INC (MED)

Currency in USD
13.10
+0.14(+1.04%)
Real-time Data·
MED Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MED is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.7313.33
52 wk Range
11.5721.98
Key Statistics
Prev. Close
12.96
Open
12.94
Day's Range
12.73-13.33
52 wk Range
11.57-21.98
Volume
120.45K
Average Volume (3m)
234.63K
1-Year Change
-36.06%
Book Value / Share
20.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MED Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.00
Upside
+14.50%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

MEDIFAST INC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

MEDIFAST INC Company Profile

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

MEDIFAST INC Earnings Call Summary for Q2/2025

  • Medifast reported Q2 2025 EPS of $0.22, beating -$0.22 forecast, but revenue fell 37.4% YoY to $105.6M
  • Stock price declined 1.75% after-hours to $13.56, reflecting concerns over revenue drop and future guidance
  • Company maintains 73.89% gross profit margins and strong cash position despite challenges
  • Q3 2025 guidance projects revenue of $70-90M and EPS range of $0.00 to -$0.60
  • Focus on expanding metabolic health offerings and coach productivity to navigate market challenges
Last Updated: 04/08/2025, 22:18
Read Full Transcript

Compare MED to Peers and Sector

Metrics to compare
MED
Peers
Sector
Relationship
P/E Ratio
36.0x−2.4x12.2x
PEG Ratio
−0.42−0.030.03
Price/Book
0.6x3.4x1.5x
Price / LTM Sales
0.3x0.5x0.9x
Upside (Analyst Target)
15.7%−7.4%17.5%
Fair Value Upside
Unlock15.8%10.9%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 15.00
(+14.50% Upside)

Earnings

Latest Release
Aug 04, 2025
EPS / Forecast
0.22 / -0.22
Revenue / Forecast
105.60M / 96.10M
EPS Revisions
Last 90 days

MED Income Statement

People Also Watch

257.28
AVAV
-2.21%
25.42
CNC
+0.81%
56.36
TSN
+0.52%
132.00
FI
-1.52%

FAQ

What Stock Exchange Does MEDIFAST Trade On?

MEDIFAST is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for MEDIFAST?

The stock symbol for MEDIFAST is "MED."

What Is the MEDIFAST Market Cap?

As of today, MEDIFAST market cap is 135.45M.

What Is MEDIFAST's Earnings Per Share (TTM)?

The MEDIFAST EPS (TTM) is 0.33.

When Is the Next MEDIFAST Earnings Date?

MEDIFAST will release its next earnings report on 09 Nov 2025.

From a Technical Analysis Perspective, Is MED a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has MEDIFAST Stock Split?

MEDIFAST has split 0 times.

How Many Employees Does MEDIFAST Have?

MEDIFAST has 504 employees.

What is the current trading status of MEDIFAST (MED)?

As of 07 Aug 2025, MEDIFAST (MED) is trading at a price of 13.10, with a previous close of 12.96. The stock has fluctuated within a day range of 12.73 to 13.33, while its 52-week range spans from 11.57 to 21.98.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.